Gökhan NERGİZOĞLU, Ufuk İLGEN

2818

MEditerranean FeVer (MEFV) gene mutations in glomerulonephritides: a clinicopathological study

MEditerranean FeVer (MEFV) gene mutations in glomerulonephritides: a clinicopathological study

Background/aim: The aim of this study is to determine the MEditerranean FeVer (MEFV) gene mutation carrier rate in patients withglomerulonephritis and to investigate the association between disease features and MEFV variants.Materials and methods: Medical records regarding clinical, laboratory, histopathological, and prognostic features of 200 adult patientswith biopsy-proven glomerulonephritis were evaluated retrospectively. Exons 2 and 10 of the MEFV gene of each patient were sequencedby next-generation sequencing. Variants were detected and compared with disease features.Results: MEFV mutation carrier rate was 25%, similar among disease subgroups, and higher than the previously reported rates fornormal populations. Demographic, clinical, and laboratory features at diagnosis did not differ in patients with and without mutations.Refractory disease rates were 73% and 40% in carriers and noncarriers of E148Q (P = 0.051). Percentage of global sclerotic glomeruliwas higher in M694V carriers than noncarriers (medians 24% vs. 0%, P = 0.047). Tubulointerstitial fibrosis was also more severe inM694V carriers. The carrier rate of M694V was 14.3% in patients eventually needing chronic renal replacement therapy (RRT) (n = 21),whereas it was 2.8% in the group without RRT (OR = 5.8 [1.28–26.3], P = 0.040).Conclusion: MEFV mutation carrier rate was higher than expected in our sample of Turkish patients with glomerulonephritis. TheE148Q mutation may be associated with refractory disease. The M694V mutation was more frequent in patients who needed chronicRRT.
PDF

___

  • Manukyan G, Aminov R. Update on pyrin functions and mechanisms of familial mediterranean fever. Front Microbiol 2016; 7: 456.
  • Simon A, van der Meer JWM, Drenth JPM. Familial autoinflammatory syndromes. In: Firestein G, Budd R, Gabriel SE, McInnes IB, O’Dell J, editors. Kelley’s Textbook of Rheumatology. 9th ed. Philadelphia, PA, USA: Elsevier Saunders; 2012. pp. 1597-1615.
  • [No authors listed.] Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997; 90: 797-807.
  • Kasifoglu T, Calisir C, Cansu DU, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol 2009; 28: 41-46.
  • Aksu K, Keser G. Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int 2011; 31: 1263-1274.
  • Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005; 84: 1-11.
  • Ben-Chetrit E, Yazici H. Thoughts on the proposed links between Behcet’s disease and familial Mediterranean fever. Clin Exp Rheumatol 2002; 20: S1-2.
  • Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A. Behcet’s disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 2000; 29: 286-295.
  • Fidder HH, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A. Crohn disease in patients with familial Mediterranean fever. Medicine (Baltimore) 2002; 81: 411-416.
  • Yahalom G, Kivity S, Lidar M, Vaknin-Dembinsky A, Karussis D, Flechter S, Ben-Chetrit E, Livneh A. Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world’s largest FMF cohorts. Eur J Neurol 2011; 18: 1146- 1150.
  • Kalyoncu M, Acar BC, Cakar N, Bakkaloglu A, Ozturk S, Dereli E, Tunca M, Kasapcopur O, Yalcinkaya F, Ozen S. Are carriers for MEFV mutations “healthy”? Clin Exp Rheumatol 2006; 24: S120-122.
  • Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soytürk M, Akar S, Tunca M et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-750.
  • Durmus D, Alayli G, Cengiz K, Yigit S, Canturk F, Bagci H. Clinical significance of MEFV mutations in ankylosing spondylitis. Joint Bone Spine 2009; 76: 260-264.
  • Inanir A, Yigit S, Karakus N, Tekin S, Rustemoglu A. Association of MEFV gene mutations with rheumatoid factor levels in patients with rheumatoid arthritis. J Investig Med 2013; 61: 593-596.
  • Koca SS, Etem EO, Isik B, Yuce H, Ozgen M, Dag MS, Isik A. Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis. Joint Bone Spine 2010; 77: 32-35.
  • Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M, Shinar Y. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 2005; 64: 1009-1014.
  • Ayaz NA, Ozen S, Bilginer Y, Erguven M, Taskiran E, Yilmaz E, Besbas N, Topaloglu R, Bakkaloglu A. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 2009; 48: 23-25.
  • Balkarli A, Tepeli E, Balkarli H, Kaya A, Cobankara V. A variant allele of the Mediterranean-fever gene increases the severity of gout. Int J Rheum Dis 2018; 21: 338-346.
  • Fidder H, Chowers Y, Ackerman Z, Pollak RD, Crusius JB, Livneh A, Bar-Meir S, Avidan B, Shinar Y. The familial Mediterranean fever (MEVF) gene as a modifier of Crohn’s disease. Am J Gastroenterol 2005; 100: 338-343.
  • Giaglis S, Mimidis K, Papadopoulos V, Thomopoulos K, Sidiropoulos P, Rafail S, Nikolopoulou V, Fragouli E, Kartalis G, Tzioufas A et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci 2006; 51: 687-692.
  • Karban A, Dagan E, Eliakim R, Herman A, Nesher S, Weiss B, Berkowitz D, Shamir R, Gershoni-Baruch R. Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn’s disease. Genes Immun 2005; 6: 134-139.
  • Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Kogan A, Achiron A. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in nonAshkenazi Jewish multiple sclerosis patients. Genes Immun 2003; 4: 197-203.
  • Shinar Y, Kosach E, Langevitz P, Zandman-Goddard G, Pauzner R, Rabinovich E, Livneh A, Lidar M. Familial Mediterranean FeVer gene (MEFV) mutations as a modifier of systemic lupus erythematosus. Lupus 2012; 21: 993-998.
  • Deniz R, Ozen G, Yilmaz-Oner S, Alibaz-Oner F, Erzik C, Aydin SZ, Inanc N, Eren F, Bayalan F, Direskeneli H et al. Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation. Lupus 2015; 24: 705-711.
  • Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behcet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003; 21: S35-37.
  • Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A. Common FMF alleles may predispose to development of Behcet’s disease with increased risk for venous thrombosis. Scand J Rheumatol 2007; 36: 48-52.
  • Tasliyurt T, Yigit S, Rustemoglu A, Gul U, Ates O. Common MEFV gene mutations in Turkish patients with Behcet’s disease. Gene 2013; 530: 100-103.
  • Ozcakar ZB, Yalcinkaya F, Cakar N, Acar B, Kasapcopur O, Uguten D, Soy D, Kara N, Uncu N, Arisoy N et al. MEFV mutations modify the clinical presentation of HenochSchonlein purpura. J Rheumatol 2008; 35: 2427-2429.
  • Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, Ocal L, Aral O, Gül A. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum 2010; 62: 3232-3236.
  • Cinar M, Dinc A, Simsek I, Erdem H, Koc B, Pay S, Tunca Y, Kilic S, Gul D. The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int 2008; 29: 37-42.
  • Unal A, Dursun A, Emre U, Tascilar NF, Ankarali H. Evaluation of common mutations in the Mediterranean fever gene in multiple sclerosis patients: is it a susceptibility gene? J Neurol Sci 2010; 294: 38-42.
  • Martinez A, Perdigones N, Cenit MC, Espino L, Varade J, Lamas JR, Santiago JL, Fernandez-Arguero R, de la Calle H, Arroyo R et al. Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis 2010; 69: 309-311.
  • Kukuy OL, Kopolovic J, Blau A, Ben-David A, Lotan D, Shaked M, Shinar Y, Dinour D, Langevitz P, Livneh A. Mutations in the familial Mediterranean fever gene of patients with IgA nephropathy and other forms of glomerulonephritis. Clin Genet 2008; 73: 146-151.
  • Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
  • KDIGO. Clinical Practice Guideline for Glomerulonephritis (GN). Cranford, NJ, USA: KDIGO; 2012.
  • Soylemezoglu O, Kandur Y, Gonen S, Duzova A, Ozcakar ZB, Fidan K, Saatci U, Bakkaloglu A, Ozguc M. Familial Mediterranean fever gene mutation frequencies in a sample Turkish population. Clin Exp Rheumatol 2016; 34: 97-100.
  • Touitou I. The Registry of Hereditary Auto-inflammatory Disorders Mutations. Montpellier, France: University of Montpellier; 2018.
  • Öztürk A, Özçakar B, Ekim M, Akar N. Is MEFV gene Arg202Gln (605 G>A) a disease-causing mutation? Turk J Med Sci 2008; 38: 205-208.
  • Yigit S, Karakus N, Tasliyurt T, Kaya SU, Bozkurt N, Kisacik B. Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients. Gene 2012; 506: 43-45.
  • Sonmez HE, Batu ED, Ozen S. Familial Mediterranean fever: current perspectives. J Inflamm Res 2016; 9: 13-20.
  • Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473-483.
  • Migita K, Nakamura T, Maeda Y, Miyashita T, Koga T, Tanaka M, Nakamura A, Komori H, Ishibashi T, Oruguchi H et al. MEFV mutations in Japanese rheumatoid arthritis patients. Clin Exp Rheumatol 2008; 26: 1091-1094.
  • Huzmeli C, Candan F, Bagci G, Alaygut D, Yilmaz A, Gedikli A, Bagci B, Timucin M, Sezgin I, Kayatas M. Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis. Clin Rheumatol 2017; 36: 2589-2594.
  • Saka S, Hirawa N, Oka A, Yatsu K, Hirukawa T, Yamamoto R, Matsusaka T, Imai E, Narita I, Endoh M et al. Genomewide association study of IgA nephropathy using 23 465 microsatellite markers in a Japanese population. J Hum Genet 2015; 60: 573-580.
  • AlFadhli S, Ghanem AA, Nizam R. Genome-wide differential expression reveals candidate genes involved in the pathogenesis of lupus and lupus nephritis. Int J Rheum Dis 2016; 19: 55-64.
  • Hutton HL, Ooi JD, Holdsworth SR, Kitching AR. The NLRP3 inflammasome in kidney disease and autoimmunity. Nephrology (Carlton) 2016; 21: 736-744.
  • Wang L, Li Q, Wang L, Li C, Yang H, Wang X, Tao H. The role of Th17/IL-17 in the pathogenesis of primary nephrotic syndrome in children. Kidney Blood Press Res 2013; 37: 332- 345.
  • Abbas AK, Lichtman AH, Pillai S. Basic Immunology: Functions and Disorders of the Immune System. 4th ed. Philadelphia, PA, USA: Elsevier Saunders; 2012.
  • Lidar M, Zandman-Goddard G, Shinar Y, Zaks N, Livneh A, Langevitz P. Systemic lupus erythematosus and familial Mediterranean fever: a possible negative association between the two disease entities--report of four cases and review of the literature. Lupus 2008; 17: 663-669.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

İsmail NALBANT, Can TUYGUN, Ufuk ÖZTÜRK, Hasan Nedim Göksel GÖKTUĞ, Ahmet Nihat KARAKOYUNLU, Volkan SELMİ, Muhammed Abdurrahim İMAMOĞLU

Osman AKDAĞ, Gökçe YILDIRAN, Mehtap KARAMEŞE

Ersöz GONCA, Figen BARUT, Deniz ŞAHİN

The prevalence of chest wall deformity in Turkish children

Bülent KOÇER, Gültekin GÜLBAHAR, Neslihan GÜLAY PERİ, Yücel AKKAŞ, Fatma Nur BARAN AKSAKAL

A comparison of the effects of perindopril arginine and amlodipine on choroidal thickness in patients with primary hypertension

Erel İÇEL, Halil İbrahim İMAMOĞLU, Nurettin AKYOL, Adem TÜRK, Aykut IÇEL

Kadir KÜÇÜKCERAN, Mehmet ERGİN, İbrahim KILINÇ, Adnan KARAİBRAHİMOĞLU, Tamer ÇOLAK, Alpay TUNCAR, Zerrin Defne DÜNDAR, Sedat KOÇAK, Abdullah Sadık GİRİŞGİN, Mehmet GÜL, Başar CANDER

Onur SAYDAM, Ercan TÜRKMEN, Oytun PORTAKAL, Mustafa ARICI, Rıza DOĞAN, Metin DEMİRCİN, İlhan PAŞAOĞLU, Mustafa YILMAZ

Maviş Emel KULAK KAYIKCI, Şadiye BACIK TIRANK, Mert ÇALIŞ, Figen ÖZGÜR, Önder GÜNAYDIN

Ebru KARACA UMAY, İbrahim GÜNDOĞDU, Eda GÜRÇAY, Erhan ÖZTÜRK, Volkan YILMAZ, Özgür KARAAHMET, Yasemin EREN, Güleser SAYLAM, Aytül ÇAKCI

Fatma ÇİFTCİ, Gülden BİLGİN, Ayşe Naz ÖZCAN, Özlem DOĞAN, Aycan YÜKSEL, Serhat EROL, Aydın ÇİLEDAĞ, Akın KAYA